Literature DB >> 9246530

Septic shock.

J A Carcillo1, R E Cunnion.   

Abstract

Although our understanding of molecular events in septic shock is growing exponentially, bedside management has changed only incrementally over the last 20 years. In pediatric and adult patients alike, treatment continues to be largely supportive. Morbidity and mortality, though gradually improving, continue to be high. The major similarities, as well as the minor differences, between pediatric and adult septic shock are reviewed in this article, with an emphasis on current clinical practice and recent clinical investigations of novel therapies.

Entities:  

Mesh:

Year:  1997        PMID: 9246530     DOI: 10.1016/s0749-0704(05)70328-6

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  4 in total

1.  Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome.

Authors:  R Arkader; E J Troster; M R Lopes; R R Júnior; J A Carcillo; C Leone; T S Okay
Journal:  Arch Dis Child       Date:  2005-12-02       Impact factor: 3.791

2.  Topomimetics of amphipathic beta-sheet and helix-forming bactericidal peptides neutralize lipopolysaccharide endotoxins.

Authors:  Xuemei Chen; Ruud P M Dings; Irina Nesmelova; Stefan Debbert; Judith R Haseman; Jacques Maxwell; Thomas R Hoye; Kevin H Mayo
Journal:  J Med Chem       Date:  2006-12-28       Impact factor: 7.446

3.  Ketamine inhibits tumor necrosis factor secretion by RAW264.7 murine macrophages stimulated with antibiotic-exposed strains of community-associated, methicillin-resistant Staphylococcus aureus.

Authors:  Thomas Spentzas; Rebekah K H Shapley; Carlos Acuna Aguirre; Elizabeth Meals; Lauren Lazar; Mark S Rayburn; Brett S Walker; B Keith English
Journal:  BMC Immunol       Date:  2011-01-25       Impact factor: 3.615

4.  Bacterial sepsis in Brazilian children: a trend analysis from 1992 to 2006.

Authors:  Cristina Malzoni Ferreira Mangia; Niranjan Kissoon; Otavio Augusto Branchini; Maria Cristina Andrade; Benjamin Israel Kopelman; Joe Carcillo
Journal:  PLoS One       Date:  2011-06-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.